Latest Biotechnology Financial Results News

Page 1 of 1
CSL Limited has released its half-year results showing a slight revenue decline amid ongoing transformation efforts, while maintaining its full-year guidance and expanding its share buyback program.
Ada Torres
Ada Torres
11 Feb 2026
Rhythm Biosciences has significantly reduced its annual loss by 44%, boosted by a 91% rise in other income, while launching a new wholly owned subsidiary, RHY GeneType Pty Ltd.
Ada Torres
Ada Torres
29 Aug 2025
Radiopharm Theranostics reported a dramatic revenue surge to $3.63 million alongside a 20% reduction in net loss for FY2025, while increasing its stake in Radiopharm Ventures to 75%.
Ada Torres
Ada Torres
29 Aug 2025